The struggle within: microbial influences on colorectal cancer
- PMID: 20848537
- PMCID: PMC3376405
- DOI: 10.1002/ibd.21354
The struggle within: microbial influences on colorectal cancer
Abstract
Recently, an unprecedented effort has been directed at understanding the interplay between chronic inflammation and development of cancer, with the case of inflammatory bowel disease (IBD)-associated colorectal cancer at the forefront of this research endeavor. The last decade has been particularly fertile, with the discovery of numerous innovative paradigms linking various inflammatory, proliferative, and innate and adaptive immune signaling pathways to the development of colorectal cancer. Because of the preponderant role of the intestinal microbiota in the initiation and progression of IBD, recent efforts have been directed at understanding the relationship between bacteria and colorectal cancer. The microbiota and its collective genome, the microbiome, form a diverse and complex ecological community that profoundly impacts intestinal homeostasis and disease states. This review will discuss the differential influence of the microbiota on the development of IBD-associated colorectal cancer and highlight the role of innate immune sensor-dependent as well as -independent mechanisms in this pathology.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.
Figures


Similar articles
-
The complex interplay between inflammation, the microbiota and colorectal cancer.Gut Microbes. 2013 May-Jun;4(3):253-8. doi: 10.4161/gmic.24220. Epub 2013 Apr 2. Gut Microbes. 2013. PMID: 23549517 Free PMC article.
-
Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.Clin Pharmacol Ther. 2016 Jun;99(6):585-7. doi: 10.1002/cpt.348. Epub 2016 Feb 19. Clin Pharmacol Ther. 2016. PMID: 26850686 Free PMC article. Review.
-
Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.Semin Immunol. 2017 Aug;32:3-13. doi: 10.1016/j.smim.2017.04.003. Epub 2017 May 2. Semin Immunol. 2017. PMID: 28465070 Review.
-
Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer.Front Cell Infect Microbiol. 2021 Feb 26;11:599734. doi: 10.3389/fcimb.2021.599734. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33738265 Free PMC article.
-
Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121. World J Gastroenterol. 2014. PMID: 25561781 Free PMC article. Review.
Cited by
-
Evolutionary foundations for cancer biology.Evol Appl. 2013 Jan;6(1):144-59. doi: 10.1111/eva.12034. Epub 2013 Jan 21. Evol Appl. 2013. PMID: 23396885 Free PMC article.
-
Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells.Am J Physiol Gastrointest Liver Physiol. 2012 Jun 15;302(12):G1405-15. doi: 10.1152/ajpgi.00543.2011. Epub 2012 Apr 19. Am J Physiol Gastrointest Liver Physiol. 2012. PMID: 22517765 Free PMC article.
-
The Microbiome as a Component of the Tumor Microenvironment.Adv Exp Med Biol. 2020;1225:137-153. doi: 10.1007/978-3-030-35727-6_10. Adv Exp Med Biol. 2020. PMID: 32030653 Review.
-
VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer.Sci Rep. 2013 Oct 8;3:2868. doi: 10.1038/srep02868. Sci Rep. 2013. PMID: 24100376 Free PMC article.
-
Diet, genes, and microbes: complexities of colon cancer prevention.Toxicol Pathol. 2014 Jan;42(1):182-8. doi: 10.1177/0192623313506791. Epub 2013 Oct 15. Toxicol Pathol. 2014. PMID: 24129759 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical